Monoclonal antibody therapy for severe asthma
Four monoclonal antibody therapies (benralizumab, mepolizumab, dupilumab and omalizumab) are available in Australia for the treatment of severe asthma in patients whose asthma is uncontrolled despite optimised standard treatment.
Work-related asthma - an update for primary health professionals
Thunderstorm Asthma : Prepare Your Patients For Spring
A flowchart for pharmacy to help identify and advise at-risk patients.
Inhaler Technique for People with Asthma or COPD
Latest evidence on the prevalence and impact of incorrect technique, plus checklists for using each inhaler correctly